Literature DB >> 15550263

In vitro recrudescence of Plasmodium falciparum parasites suppressed to dormant state by atovaquone alone and in combination with proguanil.

Mita M Thapar1, Jose P Gil, Anders Björkman.   

Abstract

We studied the viability of Plasmodium falciparum parasites reappearing in long-term cultures after repetitive exposure to atovaquone and proguanil. Parasites (F32 and FCR3) exposed to 100-5000 nM atovaquone for 96 hours were reduced to <5% of initial parasitaemia but recrudesced after 9-15 days. Also, parasites exposed to 1000 nM atovaquone for 48, 72, 96 and 144 hours recrudesced after 9, 14, 21 and 23 days respectively. Immediately after removal of the drug, only 1-3 schizonts per 10000 red blood cells were found consistently, apparently unable to produce trophozoites and thus, possibly, adopting a "dormant state". Parasites (F32 and FCR3) exposed to 500 nM atovaquone for 72 hours reappeared after 14 days. These recrudescing parasites were then re-exposed and suppressed by atovaquone in three consecutive follow-up experiments. They reappeared after 12, 11 and 9 days respectively. No known point mutations in cytochrome b gene (cytb), associated with atovaquone resistance, were detected in any recrudescing parasites. Finally, parasites (F32) exposed to various concentrations of atovaquone and proguanil in combination for 72 hours reappeared after 9-17 days. The baseline susceptibilities of the parasites to individual drugs were similar before and after recrudescence in all experiments.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15550263     DOI: 10.1016/j.trstmh.2004.01.016

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  14 in total

1.  Mitochondrial electron transport inhibition and viability of intraerythrocytic Plasmodium falciparum.

Authors:  Heather J Painter; Joanne M Morrisey; Akhil B Vaidya
Journal:  Antimicrob Agents Chemother       Date:  2010-09-20       Impact factor: 5.191

Review 2.  Malaria biology and disease pathogenesis: insights for new treatments.

Authors:  Louis H Miller; Hans C Ackerman; Xin-zhuan Su; Thomas E Wellems
Journal:  Nat Med       Date:  2013-02-06       Impact factor: 53.440

3.  Metabolomic Profiling of the Malaria Box Reveals Antimalarial Target Pathways.

Authors:  Erik L Allman; Heather J Painter; Jasmeet Samra; Manuela Carrasquilla; Manuel Llinás
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

4.  Antimalarial exposure delays Plasmodium falciparum intra-erythrocytic cycle and drives drug transporter genes expression.

Authors:  Maria Isabel Veiga; Pedro Eduardo Ferreira; Berit Aydin Schmidt; Ulf Ribacke; Anders Björkman; Ales Tichopad; José Pedro Gil
Journal:  PLoS One       Date:  2010-08-25       Impact factor: 3.240

5.  Mefloquine exposure induces cell cycle delay and reveals stage-specific expression of the pfmdr1 gene.

Authors:  Elaine B Bohórquez; Jonathan J Juliano; Hyung-Suk Kim; Steven R Meshnick
Journal:  Antimicrob Agents Chemother       Date:  2012-12-03       Impact factor: 5.191

Review 6.  Microbial persistence and the road to drug resistance.

Authors:  Nadia R Cohen; Michael A Lobritz; James J Collins
Journal:  Cell Host Microbe       Date:  2013-06-12       Impact factor: 21.023

7.  High-Dose Chloroquine for Uncomplicated Plasmodium falciparum Malaria Is Well Tolerated and Causes Similar QT Interval Prolongation as Standard-Dose Chloroquine in Children.

Authors:  Johan Ursing; Lars Rombo; Staffan Eksborg; Lena Larson; Anita Bruvoll; Joel Tarning; Amabelia Rodrigues; Poul-Erik Kofoed
Journal:  Antimicrob Agents Chemother       Date:  2020-02-21       Impact factor: 5.191

8.  Artemisinin-induced parasite dormancy: a plausible mechanism for treatment failure.

Authors:  Andrea Codd; Franka Teuscher; Dennis E Kyle; Qin Cheng; Michelle L Gatton
Journal:  Malar J       Date:  2011-03-08       Impact factor: 2.979

9.  Malaria ookinetes exhibit multiple markers for apoptosis-like programmed cell death in vitro.

Authors:  Shashini C Arambage; Karen M Grant; Ian Pardo; Lisa Ranford-Cartwright; Hilary Hurd
Journal:  Parasit Vectors       Date:  2009-07-15       Impact factor: 3.876

10.  Does the drug sensitivity of malaria parasites depend on their virulence?

Authors:  Petra Schneider; Brian Hk Chan; Sarah E Reece; Andrew F Read
Journal:  Malar J       Date:  2008-12-16       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.